NCBI PubMed Central
open access
Computational Analysis of ELOVL6 Structure and Inhibition for Rational Drug Design.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma#1074835
- Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery.#402884
- Systemic ELOVL6 activity predicts survival and represents a modifiable target of amyotrophic lateral sclerosis#243526
- Molecular Dynamics Simulations of 2‐Amino‐6‐arylsulphonylbenzonitriles Analogues as HIV Inhibitors: Interaction Modes and Binding Free Energies#471816
- d-Proline-based peptidomimetic inhibitors of anthrax lethal factor#205726
Record · ID 312651
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive